Schizophrenia Trial, Recruiting (NCT06839950)

Schizophrenia Trial, Recruiting NCT06839950 Sponsor: Centre Hospitalier Esquirol Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06839950 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 to 65 years, of any gender
People who have been admitted to a closed inpatient psychiatric unit for less than 10 days
People who are enrolled in or covered by a social security system
People who have given free, informed, and written consent (or whose legal representative has done so on their behalf, if applicable)

Who may not be able to join:

People who are unable to understand the information provided about the study
People with a confirmed sensory disability
People diagnosed with dementia
People who are pregnant
People who do not have social security coverage
People who have already taken part in this same research study during a previous hospital stay
People whose ability to communicate makes it impossible to complete the required assessment scale — for example, those with difficulties understanding French, people who are unable to speak, or people currently in physical restraint or therapeutic isolation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 5-55-43-11-27

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06839950

Sponsor: Centre Hospitalier Esquirol

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +33 5-55-43-11-27

More information: https://clinicaltrials.gov/study/NCT06839950

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 to 65 years, of any gender
People who have been admitted to a closed inpatient psychiatric unit for less than 10 days
People who are enrolled in or covered by a social security system
People who have given free, informed, and written consent (or whose legal representative has done so on their behalf, if applicable)

Who may not be able to join:

People who are unable to understand the information provided about the study
People with a confirmed sensory disability
People diagnosed with dementia
People who are pregnant
People who do not have social security coverage
People who have already taken part in this same research study during a previous hospital stay
People whose ability to communicate makes it impossible to complete the required assessment scale — for example, those with difficulties understanding French, people who are unable to speak, or people currently in physical restraint or therapeutic isolation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Esquirol

Registry

ClinicalTrials.gov

Start date

19 December 2023

Est. completion

19 December 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Scores of Sensory Sensitivity from the Adolescent/Adult Sensory Profile (Brown and Dunn, 2002) for users of the calming room and non-users of the calming room

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov